US Map / Louisiana

State LA

Clinical Trials in Louisiana

Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.

Total Trials

125

Recruiting Now

125

← Back to US Map

Top Conditions in Louisiana

Peripheral Artery Disease (3)Chronic Lymphocytic Leukemia (3)Asthma (2)Hypertension (2)Small Lymphocytic Lymphoma (2)Endometrial Cancer (2)Anatomic Stage II Breast Cancer AJCC v8 (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Idiopathic Short Stature (2)Acute Myeloid Leukemia (2)Obesity (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?

ClinicalMetric currently tracks 125 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 125. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Louisiana?

Louisiana hosts clinical trials across a broad range of medical conditions, including Peripheral Artery Disease, Chronic Lymphocytic Leukemia, Asthma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Louisiana?

To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT06880055 N/A

Shield Post-Approval Study Protocol

Colo-rectal Cancer

Guardant Health, Inc.

NCT05145491 N/A

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Epiretinal Membrane

United States, United Kingdom

Jaeb Center for Health Researc

NCT06012240 Phase 3

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...

Alopecia Areata

United States, Argentina, Australia

NCT04269902 Phase 3

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...

Chronic Lymphocytic Leukemia

United States, Canada

National Cancer Institute (NCI

NCT07166094 Phase 3

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Inves...

Endometrial Cancer

United States, Australia, Belgium

NCT06649812 Phase 2

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...

High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements

National Cancer Institute (NCI

NCT06685757 Phase 3

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...

Antibody-mediated Rejection

United States, Argentina, Australia

NCT07281430 N/A

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Tri...

Cervical Carcinoma

National Cancer Institute (NCI

NCT05304767 Phase 3

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...

United States, Bulgaria, Czechia

Karuna Therapeutics, Inc., a B

NCT04777357 Phase 3

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Carip...

United States, Puerto Rico, Russia

NCT07000357 Phase 3

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...

Cardiovascular Disease

United States, Argentina, Brazil

NCT06052267 Phase 3

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...

United States, Argentina, Australia

Teva Branded Pharmaceutical Pr

NCT06496620 Phase 2

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

United States, Australia, Canada

Uniquity One (UNI)

NCT06544499 Phase 3

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...

Primary Immune Thrombocytopenia (ITP)

United States, Austria, Bulgaria

NCT04228978 N/A

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent...

Peripheral Artery Disease

Northwestern University

NCT06596252 Phase 3

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of...

Eosinophilic Esophagitis

United States, Spain

Dr. Falk Pharma GmbH

NCT04333537 Phase 2, Phase 3

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...

Buccal Mucosa Squamous Cell Carcinoma

United States, Canada

NCT04207619 N/A

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregula...

Pennington Biomedical Research

NCT04792684 N/A

Collection of Samples USOPTIVAL Study

Colorectal Cancer (CRC)

Universal Diagnostics

NCT07285213 Phase 2

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...

Clostridioides Difficile Infection

United States, Australia, Canada

NCT06632457 Phase 3

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a L...

Metabolic Dysfunction Associated Steatohepatitis

United States, Argentina, Australia

Boehringer Ingelheim

NCT05892614 Phase 2

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patie...

Interstitial Lung Disease

aTyr Pharma, Inc.

NCT06058377 Phase 3

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...

Anatomic Stage II Breast Cancer AJCC v8

United States, Puerto Rico

National Cancer Institute (NCI

NCT03488693 Phase 3

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

United States, Canada

Canadian Cancer Trials Group

NCT06559163 Phase 2

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Belgium, Bulgaria

Zenas BioPharma (USA), LLC

Page 2 of 5 — 125 trials total

← Prev Next →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology